138 related articles for article (PubMed ID: 8997575)
1. Comparative evaluation of the short-term bactericidal potential of a steroid-antibiotic combination versus steroid in the treatment of chronic bacterial blepharitis and conjunctivitis.
Shulman DG; Sargent JB; Stewart RH; Mester U
Eur J Ophthalmol; 1996; 6(4):361-7. PubMed ID: 8997575
[TBL] [Abstract][Full Text] [Related]
2. A comparison of two ophthalmic steroid-antibiotic combinations after cataract surgery.
van Endt JJ; Veraart HG; Kramer R; Janssen AG; Sunder Raj P
Eur J Ophthalmol; 1997; 7(2):144-8. PubMed ID: 9243217
[TBL] [Abstract][Full Text] [Related]
3. Ciprofloxacin ophthalmic solution in the treatment of conjunctivitis and blepharitis: a comparison with fusidic acid.
Adenis JP; Colin J; Verin P; Riss I; Saint-Blancat P
Eur J Ophthalmol; 1996; 6(4):368-74. PubMed ID: 8997576
[TBL] [Abstract][Full Text] [Related]
4. An in vitro comparison of the susceptibilities of bacterial isolates from patients with conjunctivitis and blepharitis to newer and established topical antibiotics.
Everett SL; Kowalski RP; Karenchak LM; Landsittel D; Day R; Gordon YJ
Cornea; 1995 Jul; 14(4):382-7. PubMed ID: 7671609
[TBL] [Abstract][Full Text] [Related]
5. Ciprofloxacin ophthalmic solution versus rifamycin ophthalmic solution for the treatment of conjunctivitis and blepharitis.
Adenis JP; Colin J; Verin P; Saint-Blancat P; Malet F
Eur J Ophthalmol; 1995; 5(2):82-7. PubMed ID: 7549447
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of clinical efficacy and safety of tobramycin/dexamethasone ophthalmic suspension 0.3%/0.05% compared to azithromycin ophthalmic solution 1% in the treatment of moderate to severe acute blepharitis/blepharoconjunctivitis.
Torkildsen GL; Cockrum P; Meier E; Hammonds WM; Silverstein B; Silverstein S
Curr Med Res Opin; 2011 Jan; 27(1):171-8. PubMed ID: 21138337
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of moxifloxacin-dexamethasone eyedrops as treatment for bacterial ocular infection associated with bacterial blepharitis.
Belfort R; Gabriel L; Martins Bispo PJ; Muccioli C; Zacharias Serapicos PC; Clark L; Bell B; Bartell J; Stroman DW; Höfling-Lima AL
Adv Ther; 2012 May; 29(5):416-26. PubMed ID: 22562783
[TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of trimethoprim-containing ophthalmic solutions in humans.
Lamberts DW; Buka T; Knowlton GM
Am J Ophthalmol; 1984 Jul; 98(1):11-6. PubMed ID: 6204534
[TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of efficacy and safety of ciprofloxacin and norfloxacin ophthalmic solutions.
Adenis JP; Brasseur G; Demailly P; Malet F; Verin P; Saint-Blancat P; Retout A; Ollé P; Colin J
Eur J Ophthalmol; 1996; 6(3):287-92. PubMed ID: 8908436
[TBL] [Abstract][Full Text] [Related]
10. Comparison of topical tobramycin-dexamethasone with dexamethasone-neomycin-polymyxin and neomycin-polymyxin-gramicidin for control of inflammation after cataract surgery: results of a multicenter, prospective, three-arm, randomized, double-masked, controlled, parallel-group study.
Notivol R; Bertin D; Amin D; Whitling A; Kennedy M; Cockrum PC;
Clin Ther; 2004 Aug; 26(8):1274-85. PubMed ID: 15476908
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of the efficacy of different treatment options in patients with chronic blepharitis.
Arrúa M; Samudio M; Fariña N; Cibils D; Laspina F; Sanabria R; Carpinelli L; Mino de Kaspar H
Arch Soc Esp Oftalmol; 2015 Mar; 90(3):112-8. PubMed ID: 25542616
[TBL] [Abstract][Full Text] [Related]
12. Topical ciprofloxacin in the treatment of blepharitis and blepharoconjunctivitis.
Bloom PA; Leeming JP; Power W; Laidlaw DA; Collum LM; Easty DL
Eur J Ophthalmol; 1994; 4(1):6-12. PubMed ID: 8019124
[TBL] [Abstract][Full Text] [Related]
13. Twice-a-day versus four-times-a-day ofloxacin treatment of external ocular infection.
Friedlaender MH
CLAO J; 1998 Jan; 24(1):48-51. PubMed ID: 9474454
[TBL] [Abstract][Full Text] [Related]
14. Human conjunctivitis. II. Treatment.
Leibowitz HM; Pratt MV; Flagstad IJ; Berrospi AR; Kundsin R
Arch Ophthalmol; 1976 Oct; 94(10):1752-6. PubMed ID: 184771
[TBL] [Abstract][Full Text] [Related]
15. A controlled trial of povidone-iodine to treat infectious conjunctivitis in children.
Isenberg SJ; Apt L; Valenton M; Del Signore M; Cubillan L; Labrador MA; Chan P; Berman NG
Am J Ophthalmol; 2002 Nov; 134(5):681-8. PubMed ID: 12429243
[TBL] [Abstract][Full Text] [Related]
16. Trimethoprim-polymyxin B ophthalmic solution in treatment of surface ocular bacterial infections.
Nozik RA; Smolin G; Knowlton G; Austin R
Ann Ophthalmol; 1985 Dec; 17(12):746-8. PubMed ID: 2418736
[TBL] [Abstract][Full Text] [Related]
17. A prospective randomized study of medications after silicone intubation.
Liu D
Ophthalmic Surg Lasers; 1996 Jun; 27(6):434-7. PubMed ID: 8782256
[TBL] [Abstract][Full Text] [Related]
18. Pooled analysis of two clinical trials comparing the clinical outcomes of topical ciprofloxacin/dexamethasone otic suspension and polymyxin B/neomycin/hydrocortisone otic suspension for the treatment of acute otitis externa in adults and children.
Rahman A; Rizwan S; Waycaster C; Wall GM
Clin Ther; 2007 Sep; 29(9):1950-6. PubMed ID: 18035194
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of norfloxacin in bacterial conjunctivitis.
Huber-Spitzy V; Arocker-Mettinger E; Baumgartner I
Eur J Ophthalmol; 1991; 1(2):69-72. PubMed ID: 1821203
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of topical norfloxacin versus tobramycin in the treatment of external ocular infections.
Jacobson JA; Call NB; Kasworm EM; Dirks MS; Turner RB
Antimicrob Agents Chemother; 1988 Dec; 32(12):1820-4. PubMed ID: 3072923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
